Mrs Prue Lamerton, of Havelock North, ONZM for services to nuclear medicine
Prue Lamerton has been at the leading edge of advances in the nuclear medicine environment in New Zealand for more than four decades. She collaborated on the first delivery in New Zealand of selective internal radiation therapy (SIRT) to treat liver tumours. She was involved in the implementation of New Zealand’s first PET/CT scanner. After relocating to Hawke’s Bay, she worked to improve access for patients to nuclear medicine imaging. She undertook the first PSMA scan for prostate cancer. She served on the New Zealand Medical Radiation Technologists Board and was actively involved with the Australian and New Zealand Society of Nuclear Medicine. Mrs Lamerton has dedicated two years to establishing a Molecular Imaging and Therapy Centre in Hawke’s Bay to save patients travelling outside of the region.